Gortune Investment
Overview
Gortune Investment is a Guangzhou-based investment firm that focuses on industrial fields related to technological innovation and green development, including new energy, life sciences, and high-end manufacturing.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Chengdu Maxvax Biotechnology | Dec 2022 | Series B Extension | Co-investor |
| Gluetacs Therapeutics | May 2024 | Series A | Co-investor |
| Shenzhen Archforce Distributed Technology Co., Ltd. | Jul 2021 | VC Round | Co-investor |
| WTOIP | Nov 2018 | Strategic | Co-investor |
| Solarqt | Jun 2018 | VC Round | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Gortune Investment based?
Gortune Investment is headquartered in Guangzhou, China.
When was Gortune Investment founded?
Gortune Investment was founded in 2016.
How many portfolio companies does Gortune Investment have?
Gortune Investment has 5 portfolio companies in Caplight's dataset.
What are some companies in Gortune Investment's portfolio?
Portfolio companies visible on Caplight include Chengdu Maxvax Biotechnology, Gluetacs Therapeutics, Shenzhen Archforce Distributed Technology Co., Ltd., WTOIP, Solarqt.
What was Gortune Investment's most recent investment shown here?
Gortune Investment's most recent investment in this portfolio sample was in Gluetacs Therapeutics in 2024.
What sectors does Gortune Investment focus on?
Gortune Investment focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Energy & Sustainability, AI, Data & Cloud Infrastructure, Enterprise Software, Enterprise Software, FinTech, Enterprise Software.
What company stages does Gortune Investment focus on?
Gortune Investment typically invests at the MultiStage stage.
What is Gortune Investment's AUM?
Gortune Investment's assets under management are estimated at over $2.2B.